SEROPREVALENCE OF HIV INFECTION AMONG IV DRUG USERS IN

ICR 198905-0930-003

OMB: 0930-0128

Federal Form Document

Forms and Documents
Document
Name
Status
No forms / supporting documents in this ICR. Check IC Document Collections.
IC Document Collections
IC ID
Document
Title
Status
165954
Migrated
ICR Details
0930-0128 198905-0930-003
Historical Active 198904-0930-004
HHS/SAMHSA
SEROPREVALENCE OF HIV INFECTION AMONG IV DRUG USERS IN
No material or nonsubstantive change to a currently approved collection   No
Emergency 05/04/1989
Approved with change 05/04/1989
Retrieve Notice of Action (NOA) 05/04/1989
  Inventory as of this Action Requested Previously Approved
02/28/1991 02/28/1991 02/28/1991
6,000 0 6,000
6,000 0 6,000
0 0 0

THIS STUDY IS DESIGNED TO ESTABLISH AN ONGOING MONITORING SYSTEM TO ESTIMATE THE EXTENT OF HIV INFECTION AMONG INTRAVENOUS DRUG USERS IN SELECTED CITIES AND TO PROVI INFORMATION ON THE DEMOGRAPHIC AND BEHAVIORAL VARIABLES OF THIS POPULATION. THE STUDY WILL PROVIDE PREVALENCE RATES AND TRENDS IN SUPPORT OF FEDERAL PLANNING AND RESEARCH INTO THE PROBLEM OF AIDS AMON

None
None


No

1
IC Title Form No. Form Name
SEROPREVALENCE OF HIV INFECTION AMONG IV DRUG USERS IN

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,000 6,000 0 0 0 0
Annual Time Burden (Hours) 6,000 6,000 0 0 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$0
No
No
Uncollected
Uncollected
Uncollected
Uncollected

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
05/04/1989


© 2024 OMB.report | Privacy Policy